Crocs, Inc.
CROX
$99.11
+2.18%
Crocs, Inc. is a global designer, manufacturer, and marketer of casual lifestyle footwear and accessories, operating primarily in the Apparel - Footwear & Accessories industry under its two core brands: the iconic Crocs brand and the acquired HEYDUDE brand. The company has established itself as a distinct market leader in the comfort footwear segment, leveraging its proprietary Croslite material and brand collaborations to maintain a strong competitive identity. The current investor narrative is heavily focused on the company's recent earnings performance and its strategic efforts to revitalize the HEYDUDE brand, with recent news highlighting optimism around a clear turnaround plan for the segment and the stock's valuation following better-than-expected quarterly results.…
CROX
Crocs, Inc.
$99.11
Related headlines
CROX 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crocs, Inc.'s 12-month outlook, with a consensus price target around $128.84 and implied upside of +30.0% versus the current price.
Average Target
$128.84
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$79 - $129
Analyst target range
Analyst coverage for Crocs appears limited with only 3 analysts providing estimates for revenue and EPS, though the institutional ratings data shows activity from several major firms. The consensus sentiment leans neutral to cautious, with recent actions including a downgrade from Keybanc to 'Sector Weight' from 'Overweight' and a downgrade from Baird to 'Neutral' from 'Outperform' in early 2026, offset by maintained 'Buy' ratings from Needham. The average revenue estimate for the period is $4.56 billion, with a tight range between $4.49B and $4.63B, while the average EPS estimate is $14.83. The implied upside or downside from the current price cannot be calculated precisely as an average price target is not provided in the dataset. The target price range is also not specified, but the narrow band of revenue and EPS estimates suggests analysts have relatively aligned expectations for the company's near-term financial performance. The pattern of recent downgrades in January 2026 indicates a cooling of sentiment following the Q4 earnings report, shifting the narrative towards a 'show me' story focused on the HEYDUDE turnaround execution rather than unbridled growth optimism.
Bulls vs Bears: CROX Investment Factors
The bull and bear cases for Crocs are sharply divided, with the bear side currently holding stronger evidence due to concrete negative fundamentals: declining revenue, extreme earnings volatility, and severe market underperformance. The bull case rests on compelling but forward-looking value arguments: historically low valuation multiples and the potential for a successful HEYDUDE turnaround funded by strong cash flow. The single most important tension in the investment debate is the resolution of the HEYDUDE brand's performance. If management's clear turnaround plan succeeds, it could validate the low forward P/E and catalyze a re-rating. If it fails, the revenue decline will likely persist, keeping the stock in a value trap despite its cheap multiples. The stock's high volatility and battleground status mean this resolution will be noisy and potentially painful for investors.
Bullish
- Strong Cash Generation & FCF Margin: Crocs generated $659.2 million in free cash flow over the trailing twelve months, demonstrating robust cash conversion despite earnings volatility. This strong FCF margin provides ample internal funding for debt service and strategic initiatives, significantly de-risking the balance sheet.
- Attractive Forward Valuation Multiples: The stock trades at a forward P/E of 6.54, based on analyst EPS estimates of $14.83, which is exceptionally low for a company with a historical operating margin above 20%. This suggests the market is pricing in significant skepticism, creating a potential value opportunity if earnings recover.
- Healthy Core Brand Profitability: The Crocs brand maintains a strong gross margin of 54.68% (Q4 2025) and an operating margin of 21.97%. This indicates the core business remains fundamentally profitable and provides a stable cash flow base while management executes the HEYDUDE turnaround.
- Valuation at Historical Lows: The current Price-to-Sales ratio of 1.15 is near the bottom of its observable historical range, which has extended above 14x. This severe de-rating from past highs suggests much of the negative sentiment and growth concerns may already be priced into the stock.
Bearish
- Revenue Contraction & Growth Stall: Q4 2025 revenue of $957.64 million declined -3.25% year-over-year, continuing a sequential drop from prior quarters. This negative growth trajectory challenges the investment narrative and places immense pressure on margin expansion to drive earnings.
- Extreme Earnings Volatility & Net Loss: The company swung from a $160.1 million net profit in Q1 2025 to a massive -$492.3 million loss in Q2, resulting in a negative trailing net margin of -2.01%. This inconsistency complicates valuation and signals potential underlying operational or accounting issues.
- Significant Technical & Market Underperformance: The stock is down -19.04% over the past year and has underperformed the S&P 500 by -44.23 percentage points. Recent short-term momentum is decisively negative (-7.39% over one month), indicating persistent selling pressure and a lack of investor conviction.
- High Volatility & Battleground Status: With a beta of 1.538 and a short ratio of 2.98, CROX is 54% more volatile than the market and is a heavily contested stock. This environment can lead to sharp, news-driven price swings that demand sophisticated risk management from investors.
CROX Technical Analysis
The stock is in a volatile, range-bound consolidation phase with a negative longer-term bias, trading at 80.3% of its 52-week range ($94.94 current vs. a $73.21 low and $118.28 high) after a significant 1-year price decline of -19.04%. This positioning near the upper-mid portion of its range suggests the stock has recovered from deeper lows but faces substantial overhead resistance, indicating a market that is cautiously evaluating a potential recovery story. Recent short-term momentum is decisively negative and diverging sharply from the broader market, with the stock down -7.39% over the past month and -2.00% over three months, starkly underperforming the S&P 500 which gained 5.6% and 8.42% over the same periods, respectively. This pronounced underperformance, evidenced by a -12.99 relative strength reading over one month, signals significant stock-specific selling pressure or disappointment despite the longer-term 6-month gain of 29.36%. Key technical support is anchored at the 52-week low of $73.21, while formidable resistance sits at the 52-week high of $118.28; a sustained break above $118 would signal a major trend reversal, whereas a breakdown below $73 could trigger a new leg down. The stock's high beta of 1.538 confirms its status as 54% more volatile than the market, which, combined with a substantial short ratio of 2.98, indicates a battleground stock prone to sharp swings on news, demanding careful risk management.
Beta
1.54
1.54x market volatility
Max Drawdown
-39.0%
Largest decline past year
52-Week Range
$73-$115
Price range past year
Annual Return
-13.6%
Cumulative gain past year
| Period | CROX Return | S&P 500 |
|---|---|---|
| 1m | -6.4% | +3.3% |
| 3m | +0.9% | +6.9% |
| 6m | +26.2% | +12.4% |
| 1y | -13.6% | +23.4% |
| ytd | +14.0% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CROX Fundamental Analysis
Revenue growth has stalled and turned negative, with Q4 2025 revenue of $957.64 million representing a -3.25% year-over-year decline, and a multi-quarter trend showing a sequential drop from $996.3 million in Q3 and $1.15 billion in Q2 2025. Segment data reveals the Crocs brand generated $768.38 million (80.2% of total) while HEYDUDE contributed $189.26 million, indicating the latter brand is a significant but underperforming growth driver currently under strategic review. This revenue contraction challenges the growth narrative and places greater emphasis on margin execution and cash generation. The company remains profitable on an operating basis with a strong gross margin of 54.68% in Q4, but net income was $105.17 million, down significantly from $368.9 million in the year-ago quarter, reflecting margin compression and potential one-time charges; the trailing twelve-month net margin is negative at -2.01%, heavily impacted by a substantial net loss of -$492.3 million in Q2 2025. Operating margin remains healthy at 21.97%, but the inconsistency in quarterly profits, swinging from a $160.1 million profit in Q1 to a massive loss in Q2, points to earnings volatility that complicates the investment case. The balance sheet shows moderate financial leverage with a debt-to-equity ratio of 1.25, but the company generates robust cash flow, with free cash flow over the trailing twelve months at $659.2 million, yielding a strong FCF margin. The current ratio of 1.27 indicates adequate short-term liquidity, and the company's consistent generation of positive operating cash flow—$252.53 million in Q4 alone—provides ample internal funding for growth initiatives and debt service, mitigating balance sheet risks.
Quarterly Revenue
$957640000.0B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.54%
Latest Quarter
Free Cash Flow
$659200000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CROX Overvalued?
Given the negative trailing net income and net margin, the primary valuation metric selected is the Price-to-Sales (PS) ratio. Crocs trades at a trailing PS ratio of 1.15 and an Enterprise Value-to-Sales (EV/Sales) of 1.60, which are modest absolute multiples. The forward PE ratio of 6.54, based on estimated EPS of $14.83, suggests the market expects a significant return to profitability, creating a large gap with the negative trailing PE of -57.09. Compared to sector averages, data is not available in the provided dataset for a direct industry PS or PE comparison, limiting a precise premium/discount quantification. However, a forward PE of 6.54 appears low for a company with a historical operating margin profile above 20%, potentially indicating the market is pricing in skepticism about sustained earnings recovery or growth. Historically, the stock's own valuation has compressed dramatically; its current PS of 1.15 sits near the bottom of its observable historical range, which has extended above 14x sales in recent years. This severe de-rating from historical highs suggests the market has already priced in significant fundamental deterioration or growth concerns, possibly creating a value opportunity if the HEYDUDE turnaround and core brand stability are successfully executed.
PE
-57.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -3x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Crocs faces significant earnings volatility risk, as evidenced by the swing from a $160.1 million profit in Q1 2025 to a -$492.3 million loss in Q2, culminating in a negative trailing net margin of -2.01%. This inconsistency suggests potential one-time charges or underlying profit instability that complicates forecasting. Furthermore, revenue concentration risk is emerging, with 80.2% of Q4 sales from the Crocs brand; while this provides stability, it also highlights dependence on a single brand's longevity and the heightened importance of the struggling HEYDUDE segment's turnaround. The company carries moderate financial leverage with a debt-to-equity ratio of 1.25, though this is mitigated by robust annual free cash flow of $659.2 million.
Market & Competitive Risks: The primary market risk is valuation compression, as the stock has already de-rated dramatically from historical PS multiples above 14x to just 1.15x today. However, if the HEYDUDE turnaround falters or the core brand slows, there is risk of further multiple contraction. Competitive and brand relevance risk is perennial in the fast-moving apparel sector. The stock's high beta of 1.538 indicates it is 54% more volatile than the market, making it highly sensitive to broader market downturns or sector rotations out of consumer cyclical stocks. Recent analyst downgrades in January 2026 reflect a shift in sentiment that could limit near-term buying interest from institutional investors.
Worst-Case Scenario: The worst-case scenario involves a failure of the HEYDUDE turnaround plan coupled with a loss of momentum in the core Crocs brand, leading to sustained revenue declines and margin erosion. This could trigger further analyst downgrades, a loss of investor confidence, and a sell-off that tests the stock's 52-week low of $73.21. Given the stock's history of a -38.97% max drawdown and its current battleground status with a high short ratio, a breakdown below key support could accelerate selling. From the current price of $94.94, this scenario implies a realistic downside of approximately -23% to the 52-week low, not accounting for the potential for new lows if fundamentals deteriorate further.